Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation studyCarsten Stephan, Jacek Wilkosz, Waldemar Różański, et al.
The International Journal of Biological Markers|July 28, 2009
20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centersCarsten Stephan, Chris Bangma, Giulio Vignati, et al.
The Journal of Urology|October 23, 2012
Value of prostate specific antigen density and percent free prostate specific antigen for prostate cancer prognosisJonas Busch, Kristin Hamborg, Hellmuth-Alexander Meyer, et al.
Clinical Chemistry and Laboratory Medicine|October 8, 2008
Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standardsCarsten Stephan, Anna-Maria Kahrs, Silke Klotzek, et al.
The Journal of Urology|November 13, 2004
The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?Andreas Roemer, Lutz Schwettmann, Monika Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 23, 2015
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomyKasper Drimer Berg, Davide Soldini, Maria Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Cancer Letters|March 24, 2004
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancerKlaus Jung, Carsten Stephan, Michaela Lewandowski, et al.
Cancer|July 12, 2005
The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mLCarsten Stephan, Greta Stroebel, Marc Heinau, et al.
BJU International|March 16, 2007
Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsiesCarsten Stephan, Jürgen Kramer, Hellmuth-Alexander Meyer, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Clinical Chemistry and Laboratory Medicine|October 3, 2014
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation studyCarsten Stephan, Jacek Wilkosz, Waldemar Różański, et al.
The International Journal of Biological Markers|July 28, 2009
20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centersCarsten Stephan, Chris Bangma, Giulio Vignati, et al.
The Journal of Urology|October 23, 2012
Value of prostate specific antigen density and percent free prostate specific antigen for prostate cancer prognosisJonas Busch, Kristin Hamborg, Hellmuth-Alexander Meyer, et al.
Clinical Chemistry and Laboratory Medicine|October 8, 2008
Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standardsCarsten Stephan, Anna-Maria Kahrs, Silke Klotzek, et al.
The Journal of Urology|November 13, 2004
The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?Andreas Roemer, Lutz Schwettmann, Monika Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 23, 2015
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomyKasper Drimer Berg, Davide Soldini, Maria Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Cancer Letters|March 24, 2004
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancerKlaus Jung, Carsten Stephan, Michaela Lewandowski, et al.
Cancer|July 12, 2005
The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mLCarsten Stephan, Greta Stroebel, Marc Heinau, et al.
BJU International|March 16, 2007
Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsiesCarsten Stephan, Jürgen Kramer, Hellmuth-Alexander Meyer, et al.
Pageof 23